Cord Blood Group & Rh Factor at Ayzal Lab

Cord Blood Group & Rh Factor at Ayzal Lab

The Cord Blood Group & Rh Factor test at Ayzal Lab is a vital, non-invasive laboratory investigation performed immediately after childbirth. This specialized blood test analyzes a sample of blood collected from the umbilical cord of a newborn infant to determine their ABO blood group and Rhesus (Rh) factor. It serves as a cornerstone of neonatal screening and maternal-fetal medicine, providing immediate, life-saving clinical information. By identifying the newborn’s blood type and Rh status, healthcare providers can proactively manage potential immunological complications, most notably Hemolytic Disease of the Fetus and Newborn (HDFN), also known as erythroblastosis fetalis.

Understanding the physiological basis of this test is essential. The ABO blood group system classifies blood into types A, B, AB, or O based on the presence or absence of specific inherited antigens on the surface of red blood cells (erythrocytes). Simultaneously, the Rh factor determines the presence (+) or absence (-) of the highly immunogenic RhD antigen. When a baby is born, knowing these parameters is clinically imperative, especially if the mother is Rh-negative. Ayzal Lab, utilizing modern immunohematology techniques, ensures that this critical screening is performed with the highest degree of precision, supporting obstetricians and pediatricians in making rapid, evidence-based clinical decisions in Lahore, Pakistan.

The clinical importance of this diagnostic test extends beyond simple classification. It acts as a primary defensive screening tool. If an Rh-negative mother carries an Rh-positive fetus, maternal exposure to fetal red blood cells during pregnancy or delivery can trigger maternal sensitization. This causes the mother’s immune system to produce anti-D IgG antibodies. In subsequent pregnancies, these antibodies can cross the placenta, targeting and destroying the red blood cells of an Rh-positive fetus. Performing the Cord Blood Group & Rh Factor test immediately at birth allows clinicians to determine if the mother requires Rhophylac or Rho(D) immune globulin (RhoGAM) prophylaxis to prevent sensitization, safeguarding future pregnancies.

Clinical Procedure: What to Expect

Patient Preparation

Because the Cord Blood Group & Rh Factor test is performed on blood harvested directly from the umbilical cord immediately after delivery, there is no direct preparation required from the mother or the newborn. The following guidelines outline the clinical context of this preparation:

• No Maternal Fasting: The mother does not need to fast or alter her diet prior to labor and delivery for this test to be performed.
• No Newborn Discomfort: The procedure requires absolutely no preparation of the newborn infant, as the sample is taken post-delivery from the detached cord.
• Medical History Documentation: It is highly recommended that the mother’s prenatal records, including her blood group, Rh factor, and antibody screen results, are shared with the clinical team at Ayzal Lab prior to delivery.
• Consent and Coordination: Parents should coordinate with their obstetrician and the Ayzal Lab collection team ahead of the delivery date to ensure seamless sample collection and transport.

During the Procedure

The collection of cord blood is a sterile, painless, and highly standardized procedure that occurs immediately after the birth of the baby and the clamping of the umbilical cord. The process is executed as follows:

• Clamping of the Cord: Following the delivery of the infant, the attending healthcare provider clamps the umbilical cord in two places and cuts it, separating the newborn from the placenta. This is standard obstetric practice and is entirely painless for both mother and child.
• Sterile Cleansing: The clinical staff cleanses a segment of the remaining umbilical cord attached to the placenta with an antiseptic solution (such as alcohol or chlorhexidine) to prevent contamination with maternal blood, vaginal secretions, or environmental bacteria.
• Venipuncture of the Umbilical Vein: Using a sterile needle attached to a collection syringe or a specialized vacuum tube, the healthcare professional punctures the umbilical vein (the large vessel in the cord) and withdraws approximately 3 to 5 milliliters of blood.
• Sample Labeling and Transport: The collected blood is immediately transferred into an EDTA (anticoagulant) tube. It is meticulously labeled with the mother’s details, date, time of birth, and designated as “Cord Blood” to prevent any laboratory mix-ups.
• Laboratory Analysis: The sample is promptly transported to the immunohematology department of Ayzal Lab, where automated or manual gel card agglutination techniques are employed to determine the ABO group and Rh factor.
• Safety and Comfort: This procedure carries zero risk to both the mother and the newborn, as it utilizes blood that would otherwise be discarded with the placenta.

When is a Cord Blood Group & Rh Factor Performed?

Maternal-Fetal Rh Incompatibility Screening

Physicians routinely request this test when the mother is known to be Rh-negative. If the newborn is found to be Rh-positive, it confirms an Rh incompatibility between mother and child. This finding is the primary clinical trigger for administering Rho(D) immune globulin to the mother within 72 hours of delivery, preventing her from developing antibodies that could threaten future pregnancies.

Evaluation of Neonatal Jaundice

When a newborn exhibits early-onset jaundice (icterus neonatorum) within the first 24 hours of life, pediatricians urgently request cord blood grouping. If an ABO incompatibility exists (such as an O-positive mother and an A-positive or B-positive baby), maternal anti-A or anti-B antibodies may have crossed the placenta, causing immune-mediated hemolysis and elevated bilirubin levels.

Suspected Hemolytic Disease of the Fetus and Newborn (HDFN)

In cases where prenatal ultrasounds show signs of fetal anemia, hydrops fetalis, or when maternal antibody titers are elevated, the Cord Blood Group & Rh Factor test is performed immediately at birth. This assists neonatologists in confirming a diagnosis of HDFN, allowing them to initiate prompt treatment, such as phototherapy or exchange transfusion.

Newborns of Mothers with Unknown Blood Types

If a mother presents in active labor with no prior prenatal care or documented blood group records, clinicians must establish the immunological status of the maternal-fetal pair. Testing the cord blood immediately at delivery provides the necessary baseline data to manage potential transfusion requirements or postpartum maternal immunizations.

Routine Neonatal Screening Protocols

In many modern maternity units and clinical laboratories, cord blood typing is performed as a routine screening protocol for all deliveries. This proactive approach ensures that any unexpected blood group incompatibilities are identified early, preventing delayed diagnoses of subclinical hemolytic processes and ensuring comprehensive neonatal baseline records.

What Does a Cord Blood Group & Rh Factor Detect?

The Cord Blood Group & Rh Factor test is designed to detect specific immunological and hematological parameters. The clinical findings obtained from this test include:

• ABO Blood Group Antigen Presence: Identifies the presence of Antigen A, Antigen B, both antigens (Type AB), or the absence of both (Type O) on the neonatal red blood cells.
• RhD Antigen Status: Confirms whether the baby is Rh-positive (RhD antigen present) or Rh-negative (RhD antigen absent).
• Maternal-Fetal ABO Incompatibility: Detects potential mismatches, most commonly when an O-type mother gives birth to an A or B-type infant.
• Maternal-Fetal Rh Incompatibility: Identifies cases where an Rh-negative mother has delivered an Rh-positive baby, indicating a risk of maternal sensitization.
• Direct Antiglobulin Test (DAT) Eligibility: If an incompatibility is detected, the cord blood is further evaluated using the Coombs test to detect maternal antibodies bound to the baby’s red blood cells.
• Risk of Immune-Mediated Hemolysis: Helps predict the likelihood of rapid red blood cell destruction in the newborn.
• Predisposition to Neonatal Hyperbilirubinemia: Identifies infants at high risk for developing pathological jaundice due to hemolysis.
• Need for Postpartum Maternal Immunoprophylaxis: Directly determines whether the mother requires a postpartum dose of anti-D immunoglobulin.
• Baseline Blood Type for Potential Transfusion: Establishes the exact blood type of the newborn in case emergency blood transfusion or exchange transfusion is required due to severe anemia.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that neonatal diagnostics require rapid turnaround times to facilitate immediate clinical decisions. The Cord Blood Group & Rh Factor test is processed with high priority. Results are typically available within a few hours of sample receipt at our laboratory facility. This rapid reporting ensures that obstetricians can administer Rho(D) immune globulin to the mother within the critical 72-hour postpartum window if indicated. Patients and healthcare providers can access reports securely online through the Ayzal Lab web portal or via our dedicated digital services, ensuring seamless integration with clinical care.

Cord Blood Group & Rh Factor Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
ABO Blood Grouping	Compatible with maternal blood group (e.g., Mother O, Baby O)	ABO Incompatibility (e.g., Mother O, Baby A or B)
RhD Factor Status	Rh-Negative baby born to Rh-Negative mother, or Rh-Positive baby born to Rh-Positive mother	Rh Incompatibility (Rh-Positive baby born to Rh-Negative mother)
Direct Antiglobulin Test (Coombs)	Negative (No maternal antibodies bound to baby’s RBCs)	Positive (Maternal antibodies actively coating baby’s RBCs)
Neonatal Bilirubin Level (if reflexed)	Within normal physiological limits for hours of life	Elevated (Hyperbilirubinemia secondary to immune hemolysis)
Red Blood Cell Morphology	Normal normocytic, normochromic red blood cells	Presence of spherocytes, reticulocytosis (indicating active hemolysis)
Hemoglobin / Hematocrit	Normal neonatal reference ranges	Anemia (decreased hemoglobin due to antibody-mediated destruction)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Cord Blood Group & Rh Factor?

• Experienced healthcare professionals: Our team consists of highly qualified pathologists and laboratory technologists specializing in immunohematology.
• Patient-focused care: We prioritize the safety, comfort, and peace of mind of both mother and newborn during sample collection.
• Quality diagnostic services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure absolute accuracy.
• Professional reporting: Clear, concise, and highly detailed diagnostic reports designed for easy interpretation by clinical specialists.
• Modern diagnostic approach: Utilizing advanced gel card technology and automated systems for precise blood typing and antibody detection.
• Comfortable environment: Our collection centers and hospital-associated facilities maintain the highest standards of hygiene and patient comfort.
• Convenient location: Easily accessible facilities across Lahore, Pakistan, ensuring rapid sample transport and processing.
• Commitment to accurate diagnosis: Dedicated to providing reliable, evidence-based diagnostic insights that support timely clinical interventions.